Advances in the Detection and Diagnosis of Oral Precancerous and Cancerous Lesions

Oral and Maxillofacial Surgery Clinics of North America

Volumn 18, Issue 4, 2006, Pages 465-482

  Kalmar, John R ^a  

^a Anesthesiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; TOLONIUM CHLORIDE;

ANEUPLOIDY; ASPIRATION BIOPSY; CANCER DIAGNOSIS; CHROMOSOME NOR; CLINICAL FEATURE; CLINICAL TRIAL; CYTOCHEMISTRY; CYTOLOGY; DIAGNOSTIC PROCEDURE; EARLY DIAGNOSIS; EQUIPMENT; ERYTHROPLASIA; FLUORESCENCE; FOLLOW UP; HETEROZYGOSITY LOSS; HUMAN; LEUKOPLAKIA; MEDICAL TECHNOLOGY; META ANALYSIS; MOUTH CANCER; PUNCH BIOPSY; REVIEW; SCALPEL; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; SQUAMOUS CELL CARCINOMA; SYMPTOM; SYSTEMATIC REVIEW; TUMOR BIOPSY;

EID: 33750299969     PISSN: 10423699     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coms.2006.06.013     Document Type: Review

References (99)

1. Jemal A., Murray T., Ward E., et al. Cancer statistics, 2005. CA Cancer J Clin 55 1 (2005) 10-30
2. Morse D.E., and Kerr A.R. Disparities in oral and pharyngeal cancer incidence, mortality and survival among black and white Americans. J Am Dent Assoc 137 2 (2006) 203-212
3. Neville B.W., Damm D.D., Allen C.M., et al. Epithelial pathology. Oral and maxillofacial pathology. 2nd edition (2002), WB Saunders, Philadelphia 337-345
4. Waldron C.A., and Shafer W.G. Leukoplakia revisited. A clinicopathologic study of 3256 oral leukoplakias. Cancer 36 4 (1975) 1386-1392
5. Moore C., and Catlin D. Anatomic origins and locations of oral cancer. Am J Surg 114 4 (1967) 510-513
6. Hansen L.S., Olson J.A., and Silverman Jr. S. Proliferative verrucous leukoplakia. A long-term study of thirty patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 60 3 (1985) 285-298
7. Silverman Jr. S., and Gorsky M. Proliferative verrucous leukoplakia: a follow-up study of 54 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 84 2 (1997) 154-157
8. Shafer W.G., and Waldron C.A. Erythroplakia of the oral cavity. Cancer 36 3 (1975) 1021-1028
9. Reichart P.A., and Philipsen H.P. Oral erythroplakia-a review. Oral Oncol 41 6 (2005) 551-561
10. Mashberg A., and Samit A. Early diagnosis of asymptomatic oral oropharyngeal squamous cancers. CA Cancer J Clin 45 6 (1995) 328-351
11. Bundgaard T., Wildt J., Frydenberg M., et al. Case-control study of squamous cell cancer of the oral cavity in Denmark. Cancer Causes Control 6 1 (1995) 57-67
12. Muscat J.E., Richie Jr. J.P., Thompson S., et al. Gender differences in smoking and risk for oral cancer. Cancer Res 56 22 (1996) 5192-5197
13. Schildt E.B., Eriksson M., Hardell L., et al. Oral snuff, smoking habits and alcohol consumption in relation to oral cancer in a Swedish case-control study. Int J Cancer 77 3 (1998) 341-346
14. Lewin F., Norell S.E., Johansson H., et al. Smoking tobacco, oral snuff, and alcohol in the etiology of squamous cell carcinoma of the head and neck: a population-based case-referent study in Sweden. Cancer 82 7 (1998) 1367-1375
15. Schwartz S.M., Daling J.R., Doody D.R., et al. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst 90 21 (1998) 1626-1636
16. Lee J.J., Hong W.K., Hittelman W.N., et al. Predicting cancer development in oral leukoplakia: ten years of translational research. Clin Cancer Res 6 5 (2000) 1702-1710
17. Boffetta P., Aagnes B., Weiderpass E., et al. Smokeless tobacco use and risk of cancer of the pancreas and other organs. Int J Cancer 114 6 (2005) 992-995
18. Rosenquist K., Wennerberg J., Schildt E.B., et al. Use of Swedish moist snuff, smoking and alcohol consumption in the aetiology of oral and oropharyngeal squamous cell carcinoma. A population-based case-control study in southern Sweden. Acta Otolaryngol 125 9 (2005) 991-998
19. Accortt N.A., Waterbor J.W., Beall C., et al. Cancer incidence among a cohort of smokeless tobacco users (United States). Cancer Causes Control 16 9 (2005) 1107-1115
20. Henley S.J., Thun M.J., Connell C., et al. Two large prospective studies of mortality among men who use snuff or chewing tobacco (United States). Cancer Causes Control 16 4 (2005) 347-358
21. Folsom T.C., White C.P., Bromer L., et al. Oral exfoliative study. Review of the literature and report of a three-year study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 33 1 (1972) 61-74
22. Shklar B., Cataldo E., and Meyer I. Reliability of cytologic smear in diagnosis of oral cancer. A controlled study. Arch Otolaryngol 91 2 (1970) 158-160
23. Rovin S. An assessment of the negative oral cytologic diagnosis. J Am Dent Assoc 74 4 (1967) 759-762
24. Sciubba J.J. Improving detection of precancerous and cancerous oral lesions. J Am Dent Assoc 130 10 (1999) 1445-1457
25. Rick G.M., and Slater L. Oral brush biopsy: the problem of false positives. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 96 3 (2003) 252
26. Svirsky J.A., Burns J.C., Carpenter W.M., et al. Comparison of computer-assisted brush biopsy results with follow up scalpel biopsy and histology. Gen Dent 50 6 (2002) 500-503
27. Scheifele C., Schmidt-Westhausen A.M., Dietrich T., et al. The sensitivity and specificity of the OralCDx technique: evaluation of 103 cases. Oral Oncol 40 8 (2004) 824-828
28. Poate T.W., Buchanan J.A., Hodgson T.A., et al. An audit of the efficacy of the oral brush biopsy technique in a specialist oral medicine unit. Oral Oncol 40 8 (2004) 829-834
29. Potter T.J., Summerlin D.J., and Campbell J.H. Oral malignancies associated with negative transepithelial brush biopsy. J Oral Maxillofac Surg 61 6 (2003) 674-677
30. Huber M.A., Bsoul S.A., and Terezhalmy G.T. Acetic acid wash and chemiluminescent illumination as an adjunct to conventional oral soft tissue examination for the detection of dysplasia: a pilot study. Quintessence Int 35 5 (2004) 378-384
31. Ram S., and Siar C.H. Chemiluminescence as a diagnostic aid in the detection of oral cancer and potentially malignant epithelial lesions. Int J Oral Maxillofac Surg 34 5 (2005) 521-527
32. Kerr A.R., and Sirois D.A. Clinical evaluation of a new adjunctive technique for oral mucosal examinations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97 4 (2004) 451
33. Lane P.M., Gilhuly T., Whitehead P., et al. Simple device for the direct visualization of oral-cavity tissue fluorescence. J Biomed Opt 11 2 (2006) 024006
34. Zhang L., Ng S.P., Williams M., et al. Detection of high-risk oral premalignant lesions by multi-spectral fluorescent visualization. J Dent Res 83 Spec Issue A (2004) 1242
35. Poh C.F., Anderson D.W., Williams P.M., et al. Identification of clinically occult disease in oral cancer patients in the operating room (OR): a real-time application of fluorescence visualization. Proc Am Assoc Cancer Res 46 (2005) 1592
36. Niebel H.H., and Chomet B. In vivo staining test for delineation of oral intraepithelial neoplastic change: preliminary report. J Am Dent Assoc 68 (1964) 801-806
37. Guo Z., Yamaguchi K., Sanchez-Cespedes M., et al. Allelic losses in OraTest-directed biopsy of patients with prior upper aerodigestive tract malignancy. Clin Cancer Res 7 7 (2001) 1963-1968
38. Rosenberg D., and Cretin S. Use of meta-analysis to evaluate tolonium chloride in oral cancer screening. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 76 5 (1989) 621-627
39. Warnakulasuriya K.A., and Johnson N.W. Sensitivity and specificity of OraScan® toluidine blue mouthrinse in the detection of oral cancer and precancer. J Oral Pathol Med 25 3 (1996) 97-103
40. Epstein J.B., Oakley C., Millner A., et al. The utility of toluidine blue application as a diagnostic aid in patients previously treated for upper oropharyngeal carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 83 5 (1997) 537-547
41. Onofre M.A., Sposto M.R., and Navarro C.M. Reliability of toluidine blue application in the detection of oral epithelial dysplasia and in situ and invasive squamous cell carcinomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91 5 (2001) 535-540
42. Epstein J.B., Zhang L., Poh C., et al. Increased allelic loss in toluidine blue-positive oral premalignant lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95 1 (2003) 45-50
43. Zhang L., Williams M., Poh C.F., et al. Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome. Cancer Res 65 17 (2005) 8017-8021
44. Epstein J.B., Feldman R., Dolor R.J., et al. The utility of tolonium chloride rinse in the diagnosis of recurrent or second primary cancers in patients with prior upper aerodigestive tract cancer. Head Neck 25 11 (2003) 911-921
45. Gandolfo S., Pentenero M., Broccoletti R., et al. Toluidine blue uptake in potentially malignant oral lesions in vivo: clinical and histological assessment. Oral Oncol 42 1 (2006) 89-95
46. Silverman Jr. S., Gorsky M., and Lozada F. Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer 53 3 (1984) 563-568
47. Mincer H.H., Coleman S.A., and Hopkins K.P. Observations on the clinical characteristics of oral lesions showing histologic epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 33 3 (1972) 389-399
48. Cruz I.B., Snijders P.J., Meijer C.J., et al. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma. J Pathol 184 4 (1998) 360-368
49. Kim H.C., Kusukawa J., and Kameyama T. Clinicopathologic parameters in predicting cervical nodal metastasis in early squamous cell carcinoma of the oral cavity. Kurume Med J 40 4 (1993) 183-192
50. Martinez-Gimeno C., Rodriguez E.M., Vila C.N., et al. Squamous cell carcinoma of the oral cavity: a clinicopathologic scoring system for evaluating risk of cervical lymph node metastasis. Laryngoscope 105 7 Pt 1 (1995) 728-733
51. Po Wing Yuen A., Lam K.Y., Lam L.K., et al. Prognostic factors of clinically stage I and II oral tongue carcinoma. A comparative study of stage, thickness, shape, growth pattern, invasive front malignancy grading, Martinez-Gimeno score, and pathologic features. Head Neck 24 6 (2002) 513-520
52. Bryne M., Koppang H.S., Lilleng R., et al. New malignancy grading is a better prognostic indicator than Broders' grading in oral squamous cell carcinomas. J Oral Pathol Med 18 8 (1989) 432-437
53. Bryne M., Koppang H.S., Lilleng R., et al. Malignancy grading of the deep invasive margins of oral squamous cell carcinomas has high prognostic value. J Pathol 166 4 (1992) 375-381
54. Odell E.W., Jani P., Sherriff M., et al. The prognostic value of individual histologic grading parameters in small lingual squamous cell carcinomas. The importance of the pattern of invasion. Cancer 74 3 (1994) 789-794
55. Bryne M., Jenssen N., and Boysen M. Histological grading in the deep invasive front of T1 and T2 glottic squamous cell carcinomas has high prognostic value. Virchows Arch 427 3 (1995) 277-281
56. Spiro R.H., Guillamondegui Jr. O., Paulino A.F., et al. Pattern of invasion and margin assessment in patients with oral tongue cancer. Head Neck 21 5 (1999) 408-413
57. Bundgaard T., Rossen K., Henriksen S.D., et al. Histopathologic parameters in the evaluation of T1 squamous cell carcinomas of the oral cavity. Head Neck 24 7 (2002) 656-660
58. Martinez-Gimeno C., Molinero A.P., Castro V., et al. Prospective validation of the Martinez-Gimeno clinicopathologic scoring system (MGSS) for evaluating risk of cervical lymph node metastases of squamous cell carcinoma of the oral cavity. Head Neck 27 4 (2005) 320-325
59. Brandwein-Gensler M., Teixeira M.S., Lewis C.M., et al. Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol 29 2 (2005) 167-178
60. Kerpel S.M., Fornatora M., and Freedman P.D. Advances and new concepts in oral and maxillofacial pathology. Oral Maxillofac Surg Clin North Am 9 3 (1997) 299-315
61. Stanley M.W. Selected problems in fine needle aspiration of head and neck masses. Mod Pathol 15 3 (2002) 342-350
62. Hughes J.H., Volk E.E., and Wilbur D.C. Pitfalls in salivary gland fine-needle aspiration cytology: lessons from the College of American Pathologists Interlaboratory Comparison Program in Nongynecologic Cytology. Arch Pathol Lab Med 129 1 (2005) 26-31
63. Hoft S., Maune S., Muhle C., et al. Sentinel lymph-node biopsy in head and neck cancer. Br J Cancer 91 1 (2004) 124-128
64. Civantos F.J., Gomez C., Duque C., et al. Sentinel node biopsy in oral cavity cancer: correlation with PET scan and immunohistochemistry. Head Neck 25 1 (2003) 1-9
65. Paleri V., Rees G., Arullendran P., et al. Sentinel node biopsy in squamous cell cancer of the oral cavity and oral pharynx: a diagnostic meta-analysis. Head Neck 27 9 (2005) 739-747
66. Nieuwenhuis E.J., van der Waal I., Leemans C.R., et al. Histopathologic validation of the sentinel node concept in oral and oropharyngeal squamous cell carcinoma. Head Neck 27 2 (2005) 150-158
67. Kovacs A.F., Döbert N., Gaa J., et al. Positron emission tomography in combination with sentinel biopsy reduces the rate of elective neck dissections in the treatment of oral and oropharyngeal cancer. J Clin Oncol 22 19 (2004) 3973-3980
68. Syed R., Bomanji J.B., Nagabhushan N., et al. Impact of combined (18)F-FDG PET/CT in head and neck tumours. Br J Cancer 92 6 (2005) 1046-1050
69. 18F-fluorodeoxyglucose/positron emission tomography and positron emission tomography/computed tomography imaging of squamous head and neck cancers. Semin Nucl Med 35 4 (2005) 214-219
70. Muylle K., Castaigne C., and Flamen P. 18F-fluoro-2-deoxy-D-glucose positron emission tomographic imaging recent developments in head and neck cancer. Curr Opin Oncol 17 3 (2005) 249-253
71. Werner J.A., Dunne A.A., Ramaswamy A., et al. Sentinel node detection in N0 cancer of the pharynx and larynx. Br J Cancer 87 7 (2002) 711-715
72. Remmerbach T.W., Weidenbach H., Pomjanski N., et al. Cytologic and DNA-cytometric early diagnosis of oral cancer. Anal Cell Pathol 22 4 (2001) 211-221
73. Chattopadhyay A., Ray J.G., and Caplan D.J. AgNOR count as objective marker for dysplastic features in oral leukoplakia. J Oral Pathol Med 31 9 (2002) 512-517
74. Ray J.G., Chattopadhyay A., and Caplan D.J. Usefulness of AgNOR counts in diagnosing epithelial dysplasia. J Oral Pathol Med 32 1 (2003) 71-76
75. Guler N., Uckan S., Celik I., et al. Expression of Fas and Fas-ligand and analysis of argyrophilic nucleolar organizer regions in squamous cell carcinoma: relationships with tumor stage and grade, and apoptosis. Int J Oral Maxillofac Surg 34 (2005) 900-906
76. Remmerbach T.W., Weidenbach H., Müller C., et al. Diagnostic value of nucleolar organizer regions (AgNORs) in brush biopsies of suspicious lesions of the oral cavity. Anal Cell Pathol 25 3 (2003) 139-146
77. Sen S. Aneuploidy and cancer. Curr Opin Oncol 12 1 (2000) 82-88
78. Staibano S., Mignogna M.D., Lo Muzio L., et al. Overexpression of cyclin-D1, bcl-2, and bax proteins, proliferating cell nuclear antigen (PCNA), and DNA-ploidy in squamous cell carcinoma of the oral cavity. Hum Pathol 29 11 (1998) 1189-1194
79. Högmo A., Lindskog S., Lindholm J., et al. Preneoplastic oral lesions: the clinical value of image cytometry DNA analysis, p53 and p21/WAF1 expression. Anticancer Res 18 5B (1998) 3645-3650
80. Kim J., Shin D.M., El-Naggar A., et al. Chromosome polysomy and histological characteristic in oral premalignant lesions. Cancer Epidemiol Biomarkers Prev 10 4 (2001) 319-325
81. Noguchi M., Kinjyo H., Kohama G.I., et al. Invasive front in oral squamous cell carcinoma: image and flow cytometric analysis with clinicopathologic correlation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93 6 (2002) 682-687
82. Maraki D., Becker J., and Boecking A. Cytologic and DNA-cytometric very early diagnosis of oral cancer. J Oral Pathol Med 33 7 (2004) 398-404
83. Saiz-Bustillo R., Corchero-Martin G., Garcia-Montesinos-Perea B., et al. Oral squamous cell carcinoma. Cytometric parameters of prognostic interest. Med Oral Patol Oral Cir Bucal 10 5 (2005) 462-467
84. Couzin J., and Schirber M. Scientific misconduct. Fraud upends oral cancer field, casting doubt on prevention trial. Science 311 5760 (2006) 448-449
85. Curfman G.D., Morrissey S., and Drazen J.M. Expression of concern. [letter to the editor]. N Engl J Med 354 6 (2006) 638
86. Mao L. Can molecular assessment improve classification of head and neck premalignancy?. Clin Cancer Res 6 2 (2000) 321-322
87. Zhang L., Poh C.F., Lam W.L., et al. Impact of localized treatment in reducing risk of progression of low-grade oral dysplasia: molecular evidence of incomplete resection. Oral Oncol 37 6 (2001) 505-512
88. Rosin M.P., Cheng X., Poh C., et al. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. Clin Cancer Res 6 2 (2000) 357-362
89. Epstein J.B., Zhang L., and Rosin M. Advances in the diagnosis of oral premalignant and malignant lesions. J Can Dent Assoc 68 10 (2002) 617-621
90. Zhang L., Cheung Jr. K.J., Lam W.L., et al. Increased genetic damage in oral leukoplakia from high risk sites: potential impact on staging and clinical management. Cancer 91 11 (2001) 48-55
91. Nagpal J.K., and Das B.R. Oral cancer: reviewing the present understanding of its molecular mechanism and exploring the future directions for its effective management. Oral Oncol 39 3 (2003) 213-221
92. Rosin M.P., Lam W.L., Poh C., et al. 3p14 and 9p21 loss is a simple tool for predicting second oral malignancy at previously treated oral cancer sites. Cancer Res 62 22 (2002) 6447-6450
93. Hamana K., Uzawa K., Ogawara K., et al. Monitoring of circulating tumour-associated DNA as a prognostic tool for oral squamous cell carcinoma. Br J Cancer 92 12 (2005) 2181-2184
94. Sidransky D. Nucleic acid-based methods for the detection of cancer. Science 278 5340 (1997) 1054-1059
95. Li Y., St. John M.A., Zhou X., et al. Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res 10 24 (2004) 8442-8450
96. El-Naggar A.K., Mao L., Staerkel G., et al. Genetic heterogeneity in saliva from patients with oral squamous carcinomas: implications in molecular diagnosis and screening. J Mol Diagn 3 4 (2001) 164-170
97. Liao P.H., Chang Y.C., Huang M.F., et al. Mutation of p53 gene codon 63 in saliva as a molecular marker for oral squamous cell carcinomas. Oral Oncol 36 3 (2000) 272-276
98. St. John M.A., Li Y., Zhou X., et al. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 130 8 (2004) 929-935
99. Cheng A.J., Chen L.C., Chien K.Y., et al. Oral cancer plasma tumor marker identified with bead-based affinity-fractioned proteomic technology. Clin Chem 51 12 (2005) 2236-2244